EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma

BACKGROUND: It is urgent to explore an effective potential therapeutic strategy for ESCC. In recent years, cell-based cancer immunotherapy has become a potentially close for carcinoma therapy. Chimeric antigen receptor (CAR) T cell technology is a kind of adoptive cell therapy technique which has be...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thorac Dis
Autors principals: Shi, Hui, Yu, Feng, Mao, Yinting, Ju, Qianqian, Wu, Yingcheng, Bai, Wen, Wang, Peiwen, Xu, Ran, Jiang, Maorong, Shi, Jiahai
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6006048/
https://ncbi.nlm.nih.gov/pubmed/29997940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.04.91
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars